Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (odpre novo okno)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Vir‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indeksirano‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (odpre novo okno)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (odpre novo okno)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Vir‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indeksirano‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (odpre novo okno)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (odpre novo okno)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Vir‎: Am J Obstet Gynecol.

Indeksirano‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (odpre novo okno)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (odpre novo okno)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Vir‎: S Afr Med J 2016;106(4):399-402.

Indeksirano‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (odpre novo okno)

Prophylactic use of ergot alkaloids in the third stage of labour. (odpre novo okno)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Vir‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indeksirano‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (odpre novo okno)

Treatment for primary postpartum haemorrhage. (odpre novo okno)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Vir‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indeksirano‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (odpre novo okno)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (odpre novo okno)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Vir‎: Obstet Gynecol 2001;98(3):386-90.

Indeksirano‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (odpre novo okno)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (odpre novo okno)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Vir‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indeksirano‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (odpre novo okno)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (odpre novo okno)

Ragab A, Barakat R, Alsammani MA.

Vir‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indeksirano‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (odpre novo okno)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (odpre novo okno)

Roach MK, Abramovici A, Tita AT.

Vir‎: Am J Perinatol 2013;30(7):523-8.

Indeksirano‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (odpre novo okno)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (odpre novo okno)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Vir‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indeksirano‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (odpre novo okno)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (odpre novo okno)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Vir‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indeksirano‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (odpre novo okno)

Intravenous sulprostone infusion in the treatment of retained placenta. (odpre novo okno)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Vir‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indeksirano‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (odpre novo okno)

Carbetocin for preventing postpartum haemorrhage. (odpre novo okno)

Su LL, Chong YS, Samuel M.

Vir‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indeksirano‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (odpre novo okno)

Prostaglandins for preventing postpartum haemorrhage. (odpre novo okno)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Vir‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indeksirano‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (odpre novo okno)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (odpre novo okno)

Westhoff G, Cotter AM, Tolosa JE.

Vir‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indeksirano‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (odpre novo okno)